Thatta Cement Company Limited (PSX:THCCL)

CTI BioPharma Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	2,333	2,993	684.45	237.52	333.95	60.6
Cash & Short-Term Investments	3,185	2,993	684.45	237.52	333.95	60.6
Cash Growth	-8.36%	337.27%	188.17%	-28.88%	451.08%	-49.18%
Accounts Receivable	1,097	745.03	969.71	1,551	1,140	937.56
Other Receivables	281.25	70.13	222.78	240.94	265.33	284.19
Receivables	1,628	815.16	1,492	1,792	1,405	1,222
Inventory	1,096	472.61	1,150	863.92	662.03	774.07
Prepaid Expenses	-	5.49	3.91	4.23	2.96	4.83
Other Current Assets	145.74	1,457	507.14	717.1	347.83	352.62
Total Current Assets	6,055	5,743	3,838	3,615	2,752	2,414
Property, Plant & Equipment	5,178	4,064	3,811	4,075	4,151	4,326
Other Intangible Assets	2.05	2.93	4.09	5.27	-	-
Other Long-Term Assets	28.23	28.23	28.23	3.8	1.1	1.1
Total Assets	11,263	9,839	7,682	7,699	6,904	6,741
Accounts Payable	414.81	484.09	374.93	505.49	72.03	38.79
Accrued Expenses	1,055	1,145	677.37	264.01	326.34	299.44
Short-Term Debt	447.55	197.65	206.61	212.29	160.55	306.54
Current Portion of Long-Term Debt	751.33	751.33	751.33	313.06	250.44	87.99
Current Portion of Leases	-	-	-	6.49	-	-
Current Income Taxes Payable	429.3	650.07	-	-	-	-
Current Unearned Revenue	122.9	136.51	267.87	711.66	34.84	30.54
Other Current Liabilities	113.31	7.88	11.06	9.82	191.04	149.28
Total Current Liabilities	3,334	3,373	2,289	2,023	1,035	912.58
Long-Term Debt	-	-	-	553.84	799.46	1,045
Long-Term Leases	-	-	-	35.73	-	-
Long-Term Deferred Tax Liabilities	595.54	349.36	278.07	278.36	307.72	285.15
Other Long-Term Liabilities	3.79	22.79	2.79	2.79	2.79	2.79
Total Liabilities	3,933	3,745	2,590	2,912	2,160	2,262
Common Stock	847.18	847.18	997.18	997.18	997.18	997.18
Additional Paid-In Capital	99.72	99.72	99.72	99.72	99.72	99.72
Retained Earnings	6,160	4,351	3,115	2,828	2,754	2,512
Comprehensive Income & Other	-	-25.1	-25.1	-20.43	-2.17	-
Total Common Equity	7,107	5,273	4,187	3,905	3,849	3,609
Minority Interest	223.29	821.28	904.84	882.08	894.43	870.06
Shareholders' Equity	7,330	6,094	5,092	4,787	4,744	4,479
Total Liabilities & Equity	11,263	9,839	7,682	7,699	6,904	6,741
Total Debt	1,199	948.98	957.94	1,121	1,210	1,440
Net Cash (Debt)	1,986	2,044	-273.49	-883.9	-876.5	-1,379
Net Cash Per Share	4.34	4.47	-0.60	-1.77	-1.76	-2.77
Filing Date Shares Outstanding	423.59	423.59	498.59	498.59	498.59	498.59
Total Common Shares Outstanding	423.59	423.59	498.59	498.59	498.59	498.59
Working Capital	2,721	2,371	1,549	1,592	1,717	1,501
Book Value Per Share	16.78	12.45	8.40	7.83	7.72	7.24
Tangible Book Value	7,104	5,270	4,183	3,899	3,849	3,609
Tangible Book Value Per Share	16.77	12.44	8.39	7.82	7.72	7.24
Land	-	6.42	6.42	6.42	6.42	6.42
Buildings	-	748.44	733.63	732.86	732.86	732.86
Machinery	-	6,428	6,106	6,000	5,931	5,912
Construction In Progress	-	239.88	17.64	62.73	27.78	-
Leasehold Improvements	-	9.04	9.04	9.04	2.59	2.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.